Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
about
sameAs
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicinesBotanicals and Their Bioactive Phytochemicals for Women's HealthEffects of propolis on warfarin efficacyPatterns of medical pluralism among adults: results from the 2001 National Health Interview Survey in Taiwan.Evaluation of Herb-Drug Interactions of Hovenia dulcis Fruit Extracts.Traditional herbal medicine use among hypertensive patients in sub-Saharan Africa: a systematic review.American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathwayRepeated-dose (28 days) oral toxicity study in rats of an antiacne formula (BC-AF) derived from plants.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Procoagulant and prothrombotic effects of the herbal medicine, Dipsacus asper and its active ingredient, dipsacus saponin C, on human platelets.Herb-drug interactions: an overview of systematic reviews.Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic reviewEvaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review.Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System of Natural Health ProductsWarfarin and its interactions with foods, herbs and other dietary supplements.Herbal medicines for cardiovascular diseasesA structure-similarity-based software for the cardiovascular toxicity prediction of traditional chinese medicine.Functional foods: the case for closer evaluation.Grapefruit-drug interactions: can interactions with drugs be avoided?Hyperglycemia in poor controlled diabetes from crude tamarind herbal pill: a case studyTreatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.Herbal therapies used by hypertensive patients in TurkeyCardiovascular effects of noncardiovascular drugs.An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes.Updates on the clinical evidenced herb-warfarin interactions.Adverse effects of concentrated green tea extracts.The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy.Drug interactions in African herbal remedies.Therapeutic potential of ginseng in the management of cardiovascular disorders.The effect of garlic supplements and phytochemicals on the ADMET properties of drugs.Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux.Theranostics meets traditional Chinese medicine: rational prediction of drug-herb interactions.Epidemiological evidence linking tea consumption to human health: a review.A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin.Herbal approach in the treatment of pancytopenia.Sub-chronic safety evaluation of aqueous extract of Alangium salvifolium (L.f.) Wangerin leaves in ratsVitamin e and omega-3: what to believe: observational studies or randomized controlled trials?Comment on: Not just a vampire repellent: the adverse effects of garlic supplements in surgery.Evaluations of toxicity of Turraeanthus africanus (Méliaceae) in mice.Safety monitoring of herb-drug interactions: a component of pharmacovigilance.
P2860
Q21090750-7F5F0439-C962-4753-8638-0C786E3EE041Q28065998-9D99F819-45A4-424D-9729-38D098C8E1D2Q33600585-494BAA6A-7F98-468B-B385-C4531A26C91DQ33625915-87AC6237-EBC5-48FE-9069-E90F6AB52A48Q33647279-65EDBD51-A25F-436E-A55C-6F26547FF2DDQ33827555-6DF3F87A-3520-4037-A6A1-2D0372649FE1Q33942507-6D38A595-B76A-4EE2-A4B8-6C4FD76C9906Q34024344-1CD41307-D654-4147-9C14-A2540CC03B05Q34252907-A6238E02-2D9E-402D-A745-109E10E14B6CQ34260185-A0D3B260-7541-4760-9630-9CAFF8ABBF28Q34279245-2065669C-CF37-4BDF-8F61-670AC081A768Q34287966-B4E6109B-BF99-4AA9-A946-616DF2759EEAQ34306204-CBDAE35D-D46C-490F-B943-B1EDA6928246Q34512871-CDC83E85-F7B6-46AB-B81A-4DAE85100265Q34566453-F6C51244-0629-4FE6-8819-E2FC845568E9Q34667842-DB85CEE4-5258-47E4-A3FE-70231BBC4A63Q35764963-F0418927-C8B8-4D89-AAA4-684780831873Q35800202-7EB26E74-912F-492E-A342-B262E9290E32Q36652594-3DCEC720-55B5-45E3-BC7E-93560C0E57F5Q36719277-DAAF27FC-12C5-4613-9C27-94D0DBE68425Q37014593-1AA324CE-E7F5-4474-A40E-1B708FD653EDQ37103022-0CBE0A3C-1747-4A76-96C8-B853D9996546Q37413163-148B2774-7BF2-4AAB-9B1D-E4A18C0AE0A3Q37576766-A87BEE0B-1420-49B5-B01A-1807E8E950B0Q37686931-6374AD04-FEC8-48D3-849E-FB74E2336EC0Q37871561-D36E4903-795D-4652-9FF4-91AD2FC29193Q37873969-2D37F40B-4370-4FCD-8967-D841683C96D6Q37901060-64989917-E77B-4272-A8D6-882B7F568AE9Q37943827-FED1E3A6-BE74-4174-A074-CC02C41D2C07Q37982110-48173DBB-CF4D-401E-BD19-3B73AF2BA1ECQ38011807-ED15A3C8-7B55-4787-81EB-338DD076A39DQ38068221-AA0709FE-A930-4F73-9975-5DDECFEDC9D1Q38162968-5A38049D-CB37-4DE2-B2F6-46FEE57FDE4FQ38630265-0D74EC61-3FD2-4040-9324-A780C0E1AD97Q39134861-70FDBC12-9365-4BD4-BEBE-43E2F5F31CCBQ41129176-EC834387-2F8D-4103-8D41-18633C6B8109Q42286625-2822EAA2-8B75-49FE-89A0-BAB77E5AEC68Q42410466-E386BB59-C5FE-4F59-8177-7F7418C9E793Q43248011-96216C43-F705-4841-9159-B136DEFA8E94Q43588595-315D7177-2B91-48A7-A4DA-BDDEC2B62E78
P2860
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@ast
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@en
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@nl
type
label
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@ast
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@en
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@nl
prefLabel
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@ast
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@en
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@nl
P2093
P3181
P1476
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
@en
P2093
Angelo A Izzo
Francesca Borrelli
Giulia Di Carlo
P3181
P356
10.1016/J.IJCARD.2003.06.039
P407
P50
P577
2005-01-01T00:00:00Z